Thrombolysis-Related Hemorrhagic Infarction
- 1 June 2002
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 33 (6), 1551-1556
- https://doi.org/10.1161/01.str.0000016323.13456.e5
Abstract
Background and Purpose — The role of early and delayed recanalization after thrombolysis in the development of hemorrhagic transformation (HT) subtypes remains uncertain. We sought to explore the association between the timing of recanalization and HT risk in patients with proximal middle cerebral artery (MCA) occlusion treated with intravenous recombinant tissue plasminogen activator (rtPA) Methods — Thirty-two patients with acute stroke caused by proximal MCA occlusion treated with rtPA Results — Early and delayed recanalization was identified in 17 patients (53.1%) and 8 patients (25%), respectively. HT was detected in 14 patients (43.7%): 4 (12.5%) with hemorrhagic infarction (HI 1 ), 5 (15.6%) with HI 2 , 3 (9.3%) with parenchymal hematoma (PH 1 ), and 2 (6.8%) with PH 2 . Distribution of HT subtypes differed significantly ( P =0.025), depending on the time to artery reopening. Eight of 9 (89%), 1 of 5 (20%), and 8 of 18 (44.4%) with HI 1 -HI 2 , with PH 1 -PH 2 , and without HT, respectively, recanalized in 1 -HI 2 (11%), 4 with PH 1 -PH 2 (80%), and 3 without HT (16.6%). Neurological improvement was significantly ( P 1 -HI 2 (88%) than in those without HT (39%). Infarct volume was significantly ( P 1 -HI 2 (51.4±42 cm 3 ) than in patients with PH 1 -PH 2 (83.8±48 cm 3 ) and those without HT (98.4±84 cm 3 , P =0.021). The modified Rankin scale score was significantly lower in HI 1 -HI 2 compared with PH 1 -PH 2 patients (1.9±1.1 versus 4.6±1.2, P P =0.009.). Conclusions — Thrombolysis-related HI (HI 1 -HI 2 ) represents a marker of early successful recanalization, which leads to a reduced infarct size and improved clinical outcome.Keywords
This publication has 13 references indexed in Scilit:
- Cerebral hemorrhage after intra-arterial thrombolysis for ischemic strokeNeurology, 2001
- Delayed rt-PA Treatment in a Rat Embolic Stroke Model: Diagnosis and Prognosis of Ischemic Injury and Hemorrhagic Transformation with Magnetic Resonance ImagingJournal of Cerebral Blood Flow & Metabolism, 2001
- Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Acute stroke: usefulness of early CT findings before thrombolytic therapy.Radiology, 1997
- Prediction of Hemorrhagic Complications after Thrombolytic Therapy for Middle Cerebral Artery Occlusion: Value of Pre- and Post-therapeutic Computed Tomographic Findings and Angiographic Occlusive SiteNeurosurgery, 1996
- Hemorrhagic transformation of brain infarctNeurology, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Thrombolytic Agents in the Treatment of StrokeClinical Neuropharmacology, 1990